Approved for To treat cholestatic pruritus associated with primary biliary cholangitis. 12.1 Mechanism of Action Linerixibat is a reversible inhibitor of the ileal bile acid transporter (IBAT). It decreases the reabsorption of bile acids in the terminal ileum leading to their increased… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA…
Loading full data from Know Your Drugs Institute…